Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis Viruses”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02161510
What this trial is testing

Safety, Pharmacokinetics, and Pharmacodynamics of MK-2248 in Participants With Hepatitis C (MK-2248-002)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 13
Early research (Phase 1)Study completedNCT00998985
What this trial is testing

Grazoprevir (MK-5172) in Hepatitis C-Infected Male Participants (MK-5172-004)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 91
Testing effectiveness (Phase 2)Study completedNCT00446940
What this trial is testing

Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

Who this might be right for
Hepatitis C
Bader, Ted, M.D. 16
Early research (Phase 1)Study completedNCT04083716
What this trial is testing

Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults

Who this might be right for
Chronic Hepatitis B
Assembly Biosciences 15
Early research (Phase 1)Not Yet RecruitingNCT06661148
What this trial is testing

Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis BHBV (Hepatitis B Virus)
Epigenic Therapeutics, Inc 36
Not applicableUnknownNCT06325826
What this trial is testing

The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs

Who this might be right for
Hepatocellular Carcinoma
Egyptian Liver Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00551915
What this trial is testing

The Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)

Who this might be right for
Bacterial Infections; Virus Diseases
Merck Sharp & Dohme LLC 756
Large-scale testing (Phase 3)Study completedNCT02604017
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 703
Not applicableStudy completedNCT01767597
What this trial is testing

Application of HBV Rapid Tests as a Tool for Wide-Use Screening

Who this might be right for
Hepatitis BLiver CirrhosisCarcinoma, Hepatocellular
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 1,000
Early research (Phase 1)Study completedNCT02496897
What this trial is testing

Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B

Who this might be right for
Hepatitis B
Altimmune, Inc. 61
Not applicableNot Yet RecruitingNCT05451082
What this trial is testing

Registry-based Study in Patients With Hepatitis D Virus (HDV) Infection in China

Who this might be right for
Hepatitis D
Lai Wei 1,000
Not applicableEnded earlyNCT02503735
What this trial is testing

Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)

Who this might be right for
Hepatitis CChronic Kidney Disease
Massachusetts General Hospital 14
Not applicableUnknownNCT02809885
What this trial is testing

Hepatitis E Virus Infection in Pediatric Transplantation, a Prevalence Study

Who this might be right for
Transplantation
Hospices Civils de Lyon 226
Testing effectiveness (Phase 2)Study completedNCT00382798
What this trial is testing

Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin

Who this might be right for
Healthy VolunteersHepatitis C Virus
Pharmasset 75
Early research (Phase 1)Study completedNCT02057263
What this trial is testing

The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults

Who this might be right for
Hepatitis B
Massachusetts General Hospital 28
Post-approval studies (Phase 4)Study completedNCT00411697
What this trial is testing

Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge

Who this might be right for
Hepatitis B
GlaxoSmithKline 301
Large-scale testing (Phase 3)Study completedNCT01088659
What this trial is testing

Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.

Who this might be right for
Hepatitis D, Chronic
Hoffmann-La Roche 50
Post-approval studies (Phase 4)Study completedNCT00625560
What this trial is testing

Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA

Who this might be right for
Hepatitis B, Chronic
Yonsei University 72
Not applicableStudy completedNCT05678582
What this trial is testing

Hepatic Steatosis and Chronic Hepatitis B Virus

Who this might be right for
Chronic Hepatitis
Sohag University 91
Post-approval studies (Phase 4)Study completedNCT03567382
What this trial is testing

Arresting Vertical Transmission of Hepatitis B Virus

Who this might be right for
Hepatitis BVertical Transmission of Infectious Disease
University of North Carolina, Chapel Hill 179
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation